NEXTLEAP Cold Sore Care
A new breakthrough treatment approach for cold sores-Return to Normal in 1-2 Days!
Last Funded April 2024
$106,550
raised from 25 investors
Highlights
Fast Growth
Revenue growing 2X/yr for at least prior 6 months
Repeat Founder
Founder has started a previous company funded with $2M+
1
The cold sore market is very large but remains underserved.
2
Our novel and IP protected (via license) product provides new and improved results to customers.
3
Established with the leading online marketplaces and poised for rapid growth with added resources.
4
Continuous improvement in online marketing tools including addition of social media influencers
Featured Investor
Invested $350,000
Invested $50,000 this round & $300,000 previously
“I have agreed to be the Lead Investor in the NextLeap Wefunder crowdfunding raise because I use the NextLeap product and it has worked extremely well for me, while other products never helped me very much. I also know the founders well and I know that they have done their research carefully over many years and created an excellent product that fills a big need. I have been very fortunate to have had great success in a long investing career. My focus now is on investing in things that will ...”
Our Team
Principal
Led worldwide neurosurgical business within Pfizer
Paul StewartPrincipal
Led worldwide craniofacial business within Pfizer
At Last, A Cold Sore Treatment Approach That Makes a Difference!
